Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 17, Pages 6700-6705
Publisher
Proceedings of the National Academy of Sciences
Online
2013-04-09
DOI
10.1073/pnas.1214547110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
- (2012) Vesselina G. Cooke et al. CANCER CELL
- Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future
- (2012) Rochelle R. Arvizo et al. CHEMICAL SOCIETY REVIEWS
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- EMT as the ultimate survival mechanism of cancer cells
- (2012) Neha Tiwari et al. SEMINARS IN CANCER BIOLOGY
- Estrogen-Related Receptor Gamma Promotes Mesenchymal-to-Epithelial Transition and Suppresses Breast Tumor Growth
- (2011) C. Tiraby et al. CANCER RESEARCH
- Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge
- (2011) Rochelle R. Arvizo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
- (2011) Jones T. Nauseef et al. Nature Reviews Urology
- TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
- (2010) Sven Mahner et al. BMC CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effect of Nanoparticle Surface Charge at the Plasma Membrane and Beyond
- (2010) Rochelle R. Arvizo et al. NANO LETTERS
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
- (2010) S. Bhattacharyya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial–mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
- (2009) Angeliki Voulgari et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
- (2009) M. Shao et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Biological properties of “naked” metal nanoparticles☆
- (2008) R BHATTACHARYA et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
- (2008) C. R. Patra et al. CANCER RESEARCH
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Role of Hedgehog Signaling in Ovarian Cancer
- (2008) R. Bhattacharya et al. CLINICAL CANCER RESEARCH
- Early Events in the Pathogenesis of Epithelial Ovarian Cancer
- (2008) Charles N. Landen et al. JOURNAL OF CLINICAL ONCOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started